Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.020 Biomarker disease BEFREE <i>In vitro</i> epidermal growth factor receptor seems to be a valuable target for the prevention of posterior capsule opacification. 31789061 2019
Entrez Id: 7042
Gene Symbol: TGFB2
TGFB2
0.020 Biomarker disease BEFREE Our laboratory has previously shown that AGEs in extracellular matrix (ECM) proteins promote TGFβ2 (transforming growth factor-beta 2)-mediated epithelial-to-mesenchymal transition (EMT) of lens epithelial cells (LECs), which could play a role in fibrosis associated with posterior capsule opacification. 29588342 2018
Entrez Id: 1490
Gene Symbol: CCN2
CCN2
0.020 Biomarker disease BEFREE CTGF Contributes to the Development of Posterior Capsule Opacification: an <i>in vitro</i> and <i>in vivo</i> study. 29725265 2018
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.020 Biomarker disease BEFREE The intraocular lens as a drug delivery device for an epidermal growth factor-Receptor inhibitor for prophylaxis of posterior capsule opacification. 29855160 2018
Entrez Id: 7042
Gene Symbol: TGFB2
TGFB2
0.020 Biomarker disease BEFREE Dexamethasone inhibits TGF-β2-induced migration of human lens epithelial cells: implications for posterior capsule opacification prevention. 22406872 2012
Entrez Id: 1490
Gene Symbol: CCN2
CCN2
0.020 AlteredExpression disease BEFREE Expression of connective tissue growth factor (CTGF) mRNA in plaques of human anterior subcapsular cataracts and membranes of posterior capsule opacification. 11148599 2000
Entrez Id: 378938
Gene Symbol: MALAT1
MALAT1
0.010 AlteredExpression disease BEFREE In addition, upregulation of MALAT1 and downregulation of miR-26a were detected in human posterior capsule opacification (PCO) attached LECs and the LECs obtained from patients with anterior polar cataracts by quantitative RT-PCR (qRT-PCR). 31143769 2019
Entrez Id: 3320
Gene Symbol: HSP90AA1
HSP90AA1
0.010 Biomarker disease BEFREE HSP90 as a novel therapeutic target for posterior capsule opacification. 31589841 2019
Entrez Id: 407040
Gene Symbol: MIR34A
MIR34A
0.010 AlteredExpression disease BEFREE Furthermore, overexpression of miR-34a downregulated the levels of phosphorylated Akt, phosphorylated ERK1/2 and other cell cycle regulators. miR-34a expression was significantly reduced in posterior capsule opacification (PCO) clinical samples. 30980790 2019
Entrez Id: 5595
Gene Symbol: MAPK3
MAPK3
0.010 AlteredExpression disease BEFREE Furthermore, overexpression of miR-34a downregulated the levels of phosphorylated Akt, phosphorylated ERK1/2 and other cell cycle regulators. miR-34a expression was significantly reduced in posterior capsule opacification (PCO) clinical samples. 30980790 2019
Entrez Id: 2475
Gene Symbol: MTOR
MTOR
0.010 Biomarker disease BEFREE Mammalian target of rapamycin (mTOR) serves a central role in regulating cell growth and survival, and has been demonstrated to be involved in the pathological progression of posterior capsule opacification (PCO). 29344639 2018
Entrez Id: 1950
Gene Symbol: EGF
EGF
0.010 Biomarker disease BEFREE The previous study has demonstrated that epidermal growth factor (EGF) and EGF receptor (EGFR) signaling plays a critical role in the development of posterior capsule opacification (PCO) through regulating lens epithelial cells (LECs) proliferation. 29977916 2018
Entrez Id: 22915
Gene Symbol: MMRN1
MMRN1
0.010 Biomarker disease BEFREE Our laboratory has previously shown that AGEs in extracellular matrix (ECM) proteins promote TGFβ2 (transforming growth factor-beta 2)-mediated epithelial-to-mesenchymal transition (EMT) of lens epithelial cells (LECs), which could play a role in fibrosis associated with posterior capsule opacification. 29588342 2018
Entrez Id: 2335
Gene Symbol: FN1
FN1
0.010 Biomarker disease BEFREE Fibronectin-exposed cultures also showed increased TGFβ signaling-dependent differentiation into the two cell types responsible for posterior capsule opacification after cataract surgery, namely myofibroblasts and lens fiber cells. 30404825 2018
Entrez Id: 79075
Gene Symbol: DSCC1
DSCC1
0.010 Biomarker disease BEFREE In this cross sectional study, where posterior capsule opacification (PCO) was used as a comparator, patients were consented for one photograph with SLC and two with DCC (DCC1 and DCC2), with a slit lamp adaptor. 29909703 2018
Entrez Id: 1991
Gene Symbol: ELANE
ELANE
0.010 Biomarker disease BEFREE Our study lays the foundation for future research in lncRNAs related to EMT in HLE B-3 cells and could provide new avenues for the prevention and treatment of posterior capsule opacification (PCO). 28511643 2017
Entrez Id: 2810
Gene Symbol: SFN
SFN
0.010 Biomarker disease BEFREE SFN may help prevent posterior capsule opacification after cataract surgery. 28083623 2017
Entrez Id: 4080
Gene Symbol: MAA
MAA
0.010 Biomarker disease BEFREE P(MPC-MAA) modification significantly reduced postoperative inflammation and anterior capsule opacification (ACO), and did not affect posterior capsule opacification (PCO). 28084469 2017
Entrez Id: 406954
Gene Symbol: MIR181A2
MIR181A2
0.010 Biomarker disease BEFREE These data reveal that miR-181a can inhibit the proliferation, migration, and EMT of LECs and suggest that the restoration of miRNA-181a expression may be a potential novel therapeutic target for the prevention and treatment of posterior capsule opacification. 25626972 2015
Entrez Id: 407017
Gene Symbol: MIR26B
MIR26B
0.010 Biomarker disease BEFREE These data reveal that miR-26b can inhibit the proliferation, migration, and EMT of lens epithelial cells, and restoration of miRNA-26b may be a potential, novel therapeutic target for the prevention and treatment of posterior capsule opacification. 25063219 2014
Entrez Id: 406987
Gene Symbol: MIR204
MIR204
0.010 Biomarker disease BEFREE MicroRNA-204-5p regulates epithelial-to-mesenchymal transition during human posterior capsule opacification by targeting SMAD4. 23221074 2013
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.010 AlteredExpression disease BEFREE To investigate the correlation between connective tissue growth factor (CTGF) mRNA expression and immunohistochemical characteristics of anterior subcapsular cataract (ASC) formation as well as posterior capsule opacification (PCO) development (expression of type I collagen, alpha-smooth muscle actin and tenascin) under in vivo and under in vitro conditions in human and porcine lens epithelial cells. 11148599 2000
Entrez Id: 3371
Gene Symbol: TNC
TNC
0.010 AlteredExpression disease BEFREE To investigate the correlation between connective tissue growth factor (CTGF) mRNA expression and immunohistochemical characteristics of anterior subcapsular cataract (ASC) formation as well as posterior capsule opacification (PCO) development (expression of type I collagen, alpha-smooth muscle actin and tenascin) under in vivo and under in vitro conditions in human and porcine lens epithelial cells. 11148599 2000